Skip to main content

Table 1 Demographic characteristics of MetS patients in the two treatment groups a

From: L-carnitine ameliorated fasting-induced fatigue, hunger, and metabolic abnormalities in patients with metabolic syndrome: a randomized controlled study

  Control group (Fasting alone) Carnitine group (Fasting + L-carnitine) P-valueb
Number 15 15 1.00
Gender (Female/Male) 10/5 11/4 0.702
Age (year) 46.8 ± 10.9(27–65) 46.9 ± 9.14(37–60) 0.973
Body mass (kg) 74.2 ± 6.9(59–86) 75.1 ± 7.5(64.1-93) 0.721
BMI (kg/m2) 27.4 ± 2.0(25–32.6) 28.2 ± 1.8(26.1-32.4) 0.348
WC (cm) 90.4 ± 4.99(83–98) 94.1 ± 6.0(84–107) 0.229
Metabolic disease    
Hypertension 4 5 0.702
Impaired glucose tolerance 3 5 0.426
Dyslipidemia 12 13 0.638
  1. Abbreviation: BMI body mass index, WC waist circumference.
  2. aVariables are expressed as mean ± SD.
  3. b P-value was determined by unpaired test.